1MC0 image
Deposition Date 2002-08-04
Release Date 2002-10-02
Last Version Date 2024-11-13
Entry Detail
PDB ID:
1MC0
Keywords:
Title:
Regulatory Segment of Mouse 3',5'-Cyclic Nucleotide Phosphodiesterase 2A, Containing the GAF A and GAF B Domains
Biological Source:
Source Organism:
Mus musculus (Taxon ID: 10090)
Method Details:
Experimental Method:
Resolution:
2.86 Å
R-Value Free:
0.26
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
F 2 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:3',5'-cyclic nucleotide phosphodiesterase 2A
Gene (Uniprot):Pde2a
Mutations:Y230F, F389L
Chain IDs:A
Chain Length:368
Number of Molecules:1
Biological Source:Mus musculus
Ligand Molecules
Primary Citation
The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding.
Proc.Natl.Acad.Sci.USA 99 13260 13265 (2002)
PMID: 12271124 DOI: 10.1073/pnas.192374899

Abstact

Cyclic nucleotide phosphodiesterases (PDEs) regulate all pathways that use cGMP or cAMP as a second messenger. Five of the 11 PDE families have regulatory segments containing GAF domains, 3 of which are known to bind cGMP. In PDE2 binding of cGMP to the GAF domain causes an activation of the catalytic activity by a mechanism that apparently is shared even in the adenylyl cyclase of Anabaena, an organism separated from mouse by 2 billion years of evolution. The 2.9-A crystal structure of the mouse PDE2A regulatory segment reported in this paper reveals that the GAF A domain functions as a dimerization locus. The GAF B domain shows a deeply buried cGMP displaying a new cGMP-binding motif and is the first atomic structure of a physiological cGMP receptor with bound cGMP. Moreover, this cGMP site is located well away from the region predicted by previous mutagenesis and structural genomic approaches.

Legend

Protein

Chemical

Disease

Primary Citation of related structures